Preferred Name |
sevelamer |
|
Synonyms |
C6H12ClNO 2-(chloromethyl)oxirane; prop-2-en-1-amine |
|
ID |
http://purl.obolibrary.org/obo/dinto_DB00658 |
|
AHFScode |
92:00.00 |
|
ATCCode |
V03AE02 |
|
binds | ||
CASRN |
152751-57-0 |
|
DBBrand |
renagel |
|
Definition |
Sevelamer is a phosphate binding drug used to prevent hyperphosphataemia in patients with chronic renal failure. When taken with meals, sevelamer binds to dietary phosphate and prevents its absorption. It is marketed by Genzyme under the trade name Renagel. |
|
has pharmacological target | ||
InChI |
InChI=1S/C3H5ClO.C3H7N/c4-1-3-2-5-3;1-2-3-4/h3H,1-2H2;2H,1,3-4H2 |
|
InChIKey |
InChIKey=ZNSIZMQNQCNRBW-UHFFFAOYSA-N |
|
label |
sevelamer |
|
may interact with |
http://purl.obolibrary.org/obo/dinto_DB00685 |
|
prefixIRI |
obo2:dinto_DB00658 |
|
prefLabel |
sevelamer |
|
SMILES |
NCC=C.ClCC1CO1 |
|
Synonym |
C6H12ClNO 2-(chloromethyl)oxirane; prop-2-en-1-amine |
|
xref |
PubChem Compound:3085017 PubChem Substance:46505951 National Drug Code Directory:58468-0021-3 Drugs.com:http://www.drugs.com/cdi/sevelamer.html Drugs Product Database (DPD):2244310 PharmGKB:PA164781197 ChemSpider:2341997 Wikipedia:http://en.wikipedia.org/wiki/Sevelamer |
|
subClassOf |